je.st
news
Tag: boehringer
Sanofi, Boehringer Ingelheim to swap Merial and Boehringer Ingelheim's Consumer Healthcare businesses
2016-06-27 21:47:24| Beef
Sanofi and
Tags: consumer
businesses
healthcare
swap
Boehringer Ingelheim: Successful Participation at IPVS 2016 in Dublin
2016-06-27 02:00:00| ThePigSite - Industry News
IRELAND - The 24th International Pig Veterinary Society (IPVS) Congress was held in Dublin, Ireland, from June 7-10, 2016, simultaneously with the 8th European Symposium of Porcine Health Management. During IPVS 2016, Boehringer Ingelheim contributed with many posters and oral presentations and also with a satellite symposium in which several pig experts from different parts of the world shared and explained their vision of pig production, writes Nuria Martínez Herráez, Editor of ThePigSite's Spanish sister site ElSitioPorcino.
Tags: successful
participation
dublin
boehringer
Boehringer Ingelheim Vetnedica, Inc. welcomes Dr. Christa Goodell to its swine division
2016-05-12 18:08:11| National Hog Farmer
Boehringer Ingelheim Vetmedica, Inc. (BIVI) is pleased to welcome Christa Goodell, DVM, Ph.D., MS, as a technical manager in the BIVI Swine Division. read more
Tags: division
welcomes
swine
boehringer
Boehringer Ingelheim Vetmedica, Inc. opens new R&D facility
2016-04-21 17:38:53| National Hog Farmer
Boehringer Ingelheim Vetmedica Inc. (BIVI), a global leader in the animal health industry, today formally opened its new, state-of-the art research center, located at the Iowa State University Research Park in Ames, Iowa. The 52,000-square-foot building is dedicated entirely for research and development. The unique design was created in consultation with the group of BIVI scientists who will work in the new laboratories. read more
Tags: rd
facility
opens
boehringer
Boehringer Ingelheim's North American headquarters located in Ridgefield, CT.
2016-03-08 02:05:34| Biotech - Topix.net
Boehringer Ingelheim will receive a cash payment of $595 million as part of its collaboration with a Chicago-based pharmaceutical firm on a new drug to treat psoriasis and other immunology disorders. Boehringer Ingelheim announced the deal with AbbVie Pharmaceuticals Monday to collaborate on a biological antibody currently under phase three testing for psoriasis, a chronic skin disease that causes scaling and inflammation.
Tags: north
american
located
headquarters
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »